New flu shot for little ones shows promise in large trial
NCT ID NCT05645900
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study tested a new flu vaccine in 2,772 healthy children aged 6 to 35 months. The children received two doses of either the experimental vaccine or a control vaccine, 28 days apart. Researchers checked for side effects and measured the immune response through blood tests. The goal was to see if the new vaccine is safe and works well in young children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ab&b Biotechnology Co., Ltd.JS
Taizhou, Jiangsu, 225300, China
Conditions
Explore the condition pages connected to this study.